Ameriprise
AURA icon

Ameriprise’s Aura Biosciences AURA Stock Holding History

Ameriprise’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Sell
42,269
-573
-1% -$3.29K ﹤0.01% 3773
2025
Q4 		$233K Sell
42,842
-77,898
-65% -$463K ﹤0.01% 3882
2025
Q3 		$746K Buy
120,740
+36,182
+43% +$237K ﹤0.01% 3481
2025
Q2 		$529K Buy
84,558
+20,065
+31% +$117K ﹤0.01% 3510
2025
Q1 		$378K Sell
64,493
-21,093
-25% -$160K ﹤0.01% 3596
2024
Q4 		$704K Sell
85,586
-2,006
-2% -$18.9K ﹤0.01% 3399
2024
Q3 		$780K Buy
+87,592
New +$751K ﹤0.01% 3316

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameriprise's AURA Position: Q1 2026 in Review

Ameriprise reduced its Aura Biosciences (AURA) stake by 1.3% in Q1 2026, selling an estimated $3.29K and leaving 42,269 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #3773.

Ameriprise first reported a position in AURA in Q3 2024 and has held it in 7 quarters since. The position peaked at $780K in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Ameriprise held 42,269 shares of Aura Biosciences worth $283K as of Q1 2026.
  • Ameriprise sold 573 Aura Biosciences shares in Q1 2026, an estimated $3.29K.
  • Aura Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3773 holding.
  • Ameriprise first reported a position in Aura Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Ameriprise's Aura Biosciences position peaked at $780K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.